VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $807,253 | -21.9% | 2,664,204 | +0.8% | 0.00% | – |
| Q4 2022 | $1,033,590 | -44.5% | 2,642,775 | +0.1% | 0.00% | – |
| Q3 2022 | $1,864,000 | -47.5% | 2,640,727 | -39.9% | 0.00% | – |
| Q2 2022 | $3,552,000 | -57.8% | 4,392,854 | -13.4% | 0.00% | – |
| Q1 2022 | $8,420,000 | -29.2% | 5,072,755 | -0.2% | 0.00% | – |
| Q4 2021 | $11,897,000 | -29.2% | 5,083,919 | -5.9% | 0.00% | – |
| Q3 2021 | $16,801,000 | -8.9% | 5,402,227 | -1.8% | 0.00% | – |
| Q2 2021 | $18,434,000 | +10.5% | 5,502,567 | +2.6% | 0.00% | – |
| Q1 2021 | $16,683,000 | +10.2% | 5,364,197 | -2.6% | 0.00% | – |
| Q4 2020 | $15,142,000 | +4.4% | 5,506,248 | +8.5% | 0.00% | – |
| Q3 2020 | $14,509,000 | -22.8% | 5,073,089 | -16.3% | 0.00% | -100.0% |
| Q2 2020 | $18,789,000 | +519.7% | 6,061,043 | +90.0% | 0.00% | – |
| Q1 2020 | $3,032,000 | -26.1% | 3,190,609 | +7.4% | 0.00% | – |
| Q4 2019 | $4,101,000 | +222.7% | 2,971,540 | +10.2% | 0.00% | – |
| Q3 2019 | $1,271,000 | -19.9% | 2,695,658 | +98.7% | 0.00% | – |
| Q2 2019 | $1,587,000 | -29.7% | 1,356,944 | +12.4% | 0.00% | – |
| Q1 2019 | $2,258,000 | +261.3% | 1,207,254 | +209.4% | 0.00% | – |
| Q4 2018 | $625,000 | -65.5% | 390,141 | -47.9% | 0.00% | – |
| Q3 2018 | $1,812,000 | -12.0% | 748,826 | 0.0% | 0.00% | – |
| Q2 2018 | $2,059,000 | +425.3% | 748,826 | +568.1% | 0.00% | – |
| Q1 2018 | $392,000 | -14.2% | 112,075 | +4.8% | 0.00% | – |
| Q4 2017 | $457,000 | +82.1% | 106,950 | +64.0% | 0.00% | – |
| Q3 2017 | $251,000 | -55.2% | 65,228 | -49.3% | 0.00% | – |
| Q2 2017 | $560,000 | -43.8% | 128,545 | -29.2% | 0.00% | – |
| Q1 2017 | $996,000 | +26.6% | 181,494 | -28.5% | 0.00% | – |
| Q4 2016 | $787,000 | -54.2% | 253,839 | -50.4% | 0.00% | – |
| Q3 2016 | $1,718,000 | +21.4% | 511,395 | +42.7% | 0.00% | – |
| Q2 2016 | $1,415,000 | – | 358,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |